Literature DB >> 27156521

Transanal anopexy with HemorPex System (HPS) is effective in treating grade II and III hemorrhoids: medium-term follow-up.

M Basile1, V Di Resta2, E Ranieri2.   

Abstract

BACKGROUND: Hemorrhoidal disease is a common proctologic disorder. The HemorPex System(®) (HPS) (Angiologica, S. Martino Siccomario PV, Italy) is an innovative surgical technique based on muco-hemorrhoidopexy without Doppler guidance. The aim of this study was to evaluate the efficacy of HPS in on the treatment of grade II and III hemorrhoids.
METHODS: One hundred patients with grade II and III hemorrhoidal disease were included in the study and operated on using HPS without Doppler guidance. The procedure consists of a mucopexy carried out by means of a dedicated rotating anoscope in the 6 relatively constant positions of the terminal branches of the superior hemorrhoidal artery. A direct follow-up was carried out on 100 patients for up to 3 months. A late analysis (>12 months postoperatively) was conducted by telephone interview. At follow-up the following parameters were considered: pain, bleeding, prolapse, difficulties with hygiene and patient satisfaction with treatment.
RESULTS: Operative time was 16 ± 5 min. Three-month follow-up showed significant improvement of symptoms: pain was present in 10 (10 %) patients versus 45 (45 %) preoperatively; bleeding in 13 (13 %) of patients versus 57 (57 %) preoperatively; prolapse in 13 (13 %) of patients versus 45 (45 %) preoperatively and difficulties with hygiene in 1 (1 %) versus 24 (24 %) preoperatively (all p < 0.05). At longer follow-up which was available in 67 patients, 5 patients (7.5 %) had recurrence and were reoperated on at 8, 10, 24, 26 and 36 months, respectively after the first procedure. As regards patient satisfaction, complete satisfaction was reported by 95/100 patients (95 %) at 3 months, 62/67 (92.5 %) at 12 months and 8/56 (85.7 %) at 24 months; partial satisfaction was reported by 3/100 patients (3 %) with intermittent bleeding at 3 months, 3/67 (4.4 %) patients at 12 months and 6/56 (10.7 %) patients at 24 months, all with either intermittent bleeding or prolapse. Dissatisfaction with the procedure was reported by in 1/100 (1 %) patient at 3 months, 2/67 (2.9 %) at 12 months and 2/56 (3.6 %) at 24 months including patients who underwent reintervention.
CONCLUSIONS: HPS can be used in the treatment of grade II and III hemorrhoidal disease. Our results show that this simple technique may be an effective but due to the important limitations of this study (loss to follow-up, non-comparative study) further studies are required.

Entities:  

Keywords:  Doppler; HemorPex System (HPS); Hemorrhoids; Muco-hemorrhoidopexy

Mesh:

Year:  2016        PMID: 27156521     DOI: 10.1007/s10151-016-1451-5

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN: 1123-6337            Impact factor:   3.781


  29 in total

Review 1.  [Pathophysiology of hemorrhoids].

Authors:  H P Bruch; U J Roblick
Journal:  Chirurg       Date:  2001-06       Impact factor: 0.955

Review 2.  A systematic review comparing transanal haemorrhoidal de-arterialisation to stapled haemorrhoidopexy in the management of haemorrhoidal disease.

Authors:  M S Sajid; U Parampalli; P Whitehouse; P Sains; M R McFall; M K Baig
Journal:  Tech Coloproctol       Date:  2011-12-20       Impact factor: 3.781

3.  Is Doppler ultrasonography essential for hemorrhoidal artery ligation?

Authors:  S Avital; R Inbar; E Karin; R Greenberg
Journal:  Tech Coloproctol       Date:  2012-06-01       Impact factor: 3.781

4.  Anatomical branches of the superior rectal artery in the distal rectum.

Authors:  J P Schuurman; P M N Y H Go; R L A W Bleys
Journal:  Colorectal Dis       Date:  2008-10-31       Impact factor: 3.788

5.  To improve the "target" of transanal hemorrhoidal dearterialization.

Authors:  C Ratto; A Parello
Journal:  Tech Coloproctol       Date:  2011-04-20       Impact factor: 3.781

6.  A prospective and comparative study between stapled hemorrhoidopexy and hemorrhoidal artery ligation with mucopexy.

Authors:  A Béliard; F Labbé; D de Faucal; J-M Fabreguette; P Pouderoux; F Borie
Journal:  J Visc Surg       Date:  2014-04-13       Impact factor: 2.043

7.  [Hemorpex system: a new procedure for the treatment of haemorrhoids].

Authors:  Carlo Iachino; Yaima Guerrero; Francesco Sias; Luca Milone; Martino Saccone; Giuseppe Franco Giordano; Máximo Giordano
Journal:  Cir Esp       Date:  2009-06-21       Impact factor: 1.653

8.  Assessment of haemorrhoidal artery network using colour duplex imaging and clinical implications.

Authors:  C Ratto; A Parello; L Donisi; F Litta; G Zaccone; G B Doglietto
Journal:  Br J Surg       Date:  2011-10-21       Impact factor: 6.939

9.  The HubBLe trial: haemorrhoidal artery ligation (HAL) versus rubber band ligation (RBL) for haemorrhoids.

Authors:  Jim Tiernan; Daniel Hind; Angus Watson; Allan J Wailoo; Michael Bradburn; Neil Shephard; Katie Biggs; Steven Brown
Journal:  BMC Gastroenterol       Date:  2012-10-25       Impact factor: 3.067

10.  Transanal dearterialization with targeted mucopexy is effective for advanced haemorrhoids.

Authors:  P Giordano; I Tomasi; A Pascariello; E Mills; S Elahi
Journal:  Colorectal Dis       Date:  2014-05       Impact factor: 3.788

View more
  3 in total

1.  Doppler-guided hemorrhoidal dearterialization with laser (HeLP): a prospective analysis of data from a multicenter trial.

Authors:  P Giamundo; A Braini; G Calabro'; N Crea; P De Nardi; F Fabiano; M Lippa; A Mastromarino; A M Tamburini
Journal:  Tech Coloproctol       Date:  2018-08-29       Impact factor: 3.781

2.  Hemorrhoid laser procedure with suture-pexy (HeLPexx): a novel effective procedure to treat hemorrhoidal disease.

Authors:  P Giamundo; M De Angelis; A Mereu
Journal:  Tech Coloproctol       Date:  2020-01-28       Impact factor: 3.781

3.  A Case Report of Acute Diverticulitis in "Pseudodiverticulosis" after Hemorpex System® Procedure.

Authors:  Tommaso Testa; Federico Costanzo
Journal:  Case Rep Surg       Date:  2016-11-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.